3-(3-Methylpyrrolidin-3-yl)pyridine, 95%, 25mg

(2,2-Difluorobenzo[d][1,3]dioxol-5-yl)methanol, 95.0%, 1g

4-Bromo-2-fluorocinnamic acid, 98.0%, 100g

1,4-Dioxaspiro[4.5]decane-8,8-diyldimethanol, 95.0%, 25g

1,1-Dimethylpiperidinium Chloride>98.0%(T)5g

(5-Chloro-6-isobutoxypyridin-3-yl)boronic acid, 95.0%, 250mg

(1-Isobutyl-3-(trifluoromethyl)-1H-pyrazol-5-yl)boronic acid, 95.0%, 1g

1,4-Dimethyl-2-nitrobenzene, 95.0%, 100g

1,2,3,4-Tetrahydroquinolin-3-amine, 95.0%, 250mg

Microliter syringe GASTIGHT® series 1700 Point type 3, 10 µl, 1701 RNR, 1 piece

4-Amino-5-trifluoromethyl-4H-1,2,4-triazole-3-thiol, 95.0%, 2.5g

1H-Benzoimidazole-2-carboxaldehyde, 95.0%, 100g

(3R)-6-FLUORO-2,3-DIHYDROBENZO[B]FURAN-3-YLAMINE HYDROCHLORIDE, 95.0%, 1g